Term
Cyclosporine
(pp 630 text) |
|
Definition
mech of action:
inhibits interleuken 1,2 receptor production.
inhibits T-cell interaction and responsiveness
used for:
rheumatoid arthritis
possibly systemic lupus erythematus
pharmakinetics:
metabolized by CYP3A
Grapefrui increases bioavailability |
|
|
Term
Leflunomide
(pp 631 text) |
|
Definition
Mech of Action:
rapid conversion in intestine & plasma =A77-1726
inhibits dihydroorotate dehydrogenase
inhibit T-cell proliferation
inhibit B-cell autoantibodies production
Indications:
Rheumatoid Arthritis (include inhibition bone damage)
Adverse Effects:
diarrhea
dose dependent liver enzyme elevation
contraindicated in pregnancy |
|
|
Term
Methotrexate
(pp 631 text) |
|
Definition
Mech of Action:
1) low dose inhibit AICAR
2)inhibits proliferation, stimulates apoptosis in immune-inflammatory cells.
Indications:
DMARD of 1st choice Rx Rheumatoid Arthritis
Pharmakinetics:
excreted in urine/bile Adverse effects:
nausea/mucosal ulcers most common |
|
|
Term
|
Definition
sulfoxide prodrug
reversibly metabolized to active
excreted in bile > reabsorbed from intestine
indications:
Rheumatic dz
supress familial intestional polyposis
*may inhibit CA
side effects:
Steven Johnsons (SJS)
reversible liver damage |
|
|
Term
|
Definition
nonselective COX inhibitor
NOT OFTEN USED
NOT EFFECTIVE AGAINST GOUT
Adverse reactions:
thrombocytopenia (rare) |
|
|
Term
|
Definition
Napthylpropionic acid derivative
only NSAID single entantiomer
indications:
Rheumatologic (available as oral suspension, slow release, OTC, topical, ophthalmic drop)
Adverse:
GI bleed 2x > OTC Ibuprofen
|
|
|
Term
|
Definition
racemic acetic acid derivative |
|
|
Term
|
Definition
simple derivative of phenylpropionic acid
equivalent to 4g ASA (as NSAID)
CLOSES PATENT DUCTUS ARTERIOSUS
contraindications:
don't use individuals with nasal polyps, angioedema.
adverse drug reactions:
ASA |
|
|
Term
|
Definition
phenylacetic acid derivative
nonselective COX inhibitor
|
|
|
Term
Celebrex/Celecoxib
(pp 626 text) |
|
Definition
COX 2 inhibitor
sulfonamide
metabolized by CYP2C9
adverse reactions:
rash
ocassionally interacts with warafin
|
|
|
Term
Allopurinol
(pp 638 text) |
|
Definition
standard of care for GOUT
prophylaxis
mech of action:
inhibits xanthine oxidase > reduces total uric acid |
|
|
Term
|
Definition
1st nonpurine inhibitor of xanthine oxidase |
|
|
Term
|
Definition
alkaloid isolated from autumn crocus
Indicated:
Was 1st line Gout drug (supplanted by NSAIDS)
prophylaxis now
Gouty Arthritis
prevent mediterranean fever
Mech of action:
binds to intercellular protein tubulin > inhibits formation of leukotrine B4
Adverse:
IV very toxic to bone marrow
diarrhea,nausea, vomiting |
|
|
Term
|
Definition
Mech of action:
inhibits T-cell activation
Indications:
moderate to severe RA
slows radiographic pregression
Side effects:
increased risk of URI infection
|
|
|
Term
Azathioprine
(pp 629-630 text) |
|
Definition
Mech of Action:
6-Thioguanine (active form)
supresses: inosinic acid synthesis,B,T-cell function, Ig production, interleuken-2 secretion
Pharmcokinetics:
bimodal (rapid 4x > slow)
Indicated:
RA, psoriatic arthritis, reacitve arthritis, polymyositis, S'lupus erythematous, Bechet's dz
Adverse:
bone marrow sup, GI, increase risk inf |
|
|
Term
Cyclophosphamide
(pp 630 text) |
|
Definition
Mech of action:
major metabolite is phosphoramide mustard which cross links DNA to prevent cell replication.
supresses T,B cell
Indications:
RA
systemic lupus erythematous
vasculitis
Wegener's granulomatosis
severe rheumatic dzs |
|
|